Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
01/22/20203:08PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IMGNImmunoGen Inc
01/22/20203:01PMBusiness WireImmunoGen Announces Proposed Public Offering of Common StockNASDAQ:IMGNImmunoGen Inc
01/13/20205:08AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
01/03/20203:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/03/20203:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/03/20209:46AMBusiness WireImmunoGen Announces Webcast of Presentation and Q&A at the 38th Annual J.P. Morgan Healthcare ConferenceNASDAQ:IMGNImmunoGen Inc
01/02/20208:28AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/02/20208:27AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/02/20207:30AMBusiness WireImmunoGen Announces Webcast of Presentation and Q&A at the 38th Annual J.P. Morgan Healthcare ConferenceNASDAQ:IMGNImmunoGen Inc
12/31/20193:01PMBusiness WireImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
12/20/201912:35PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IMGNImmunoGen Inc
12/20/201912:33PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IMGNImmunoGen Inc
12/20/201912:31PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:IMGNImmunoGen Inc
12/20/201912:28PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:IMGNImmunoGen Inc
12/20/201912:25PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:IMGNImmunoGen Inc
12/20/201912:23PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:IMGNImmunoGen Inc
12/20/20196:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
12/17/20195:38AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
12/17/20195:30AMBusiness WireImmunoGen Announces Accelerated Approval Pathway for Mirvetuximab Soravtansine in Ovarian CancerNASDAQ:IMGNImmunoGen Inc
12/09/20192:01PMBusiness WireImmunoGen Presents Updated Findings from Phase 1 Study of IMGN632 at ASH Annual MeetingNASDAQ:IMGNImmunoGen Inc
12/06/20191:10PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:IMGNImmunoGen Inc
12/06/201912:54PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:IMGNImmunoGen Inc
11/26/20193:47PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
11/26/20193:30PMBusiness WireImmunoGen Announces Webcast of Presentation at the Piper Jaffray 31st Annual Healthcare ConferenceNASDAQ:IMGNImmunoGen Inc
11/21/20193:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/06/20198:01AMBusiness WireImmunoGen to Present New Data on IMGN632 at 61st ASH Annual MeetingNASDAQ:IMGNImmunoGen Inc
11/05/20194:32PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
11/01/20195:55AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
11/01/20195:30AMBusiness WireImmunoGen Reports Recent Progress and Third Quarter 2019 Financial ResultsNASDAQ:IMGNImmunoGen Inc
10/18/20193:30PMBusiness WireImmunoGen Announces Conference Call to Discuss Its Third Quarter 2019 Operating ResultsNASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN

Your Recent History

Delayed Upgrade Clock